Precipio Schedules Q3-2023 Shareholder Update Call for November 20th

Specialty diagnostics provider focused on cancer, Precipio, Inc. PRPO, has announced the scheduling of its shareholder update call for the third quarter of 2023. The conference call, designed to discuss the company's recent progress and future plans, is on the docket for November 20th, 2023, at 5:00 PM ET. Interested parties are encouraged to tune in to gain insights on the company’s developments across its core business areas.

Corporate Update on Core Businesses

Precipio's call promises a comprehensive update on the operations and advancements within their primary sectors of activity. Having established a strong foothold in the United States oncology market with its diagnostic offerings and reagent technology, this update is a key indication of the company's trajectory. The discussion is expected to cover various aspects of the company's performance and strategic direction, essential for investors and stakeholders of PRPO.

About Precipio, Inc.

Headquartered in New Haven, Connecticut, Precipio, Inc. has established itself as a prominent entity in the area of cancer diagnostics and reagent technology. Catering to the oncology market across the United States, PRPO aims to leverage its expertise to deliver leading-edge diagnostic products and services, thereby impacting patient care positively. This upcoming shareholder call represents another step in communicating their ongoing commitment to growth and excellence.

Precipio, update, call